Cachexia Treatment
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
196
NCT05529849
A Study to Assess the Safety, Tolerability and Pharmacokinetics of TCMCB07 in Single and Multiple Ascending Doses in Health Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 12, 2022
Completion: Feb 20, 2023
NCT06937177
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy
Phase: Phase 2
Start: Apr 28, 2025
Completion: Sep 30, 2026
Loading map...